Richard A. Edlin is Director of EAGLE PHARMACEUTICALS, INC.. Currently has a direct ownership of 22,600 shares of EGRX, which is worth approximately $13,560. The most recent transaction as insider was on Sep 06, 2022, when has been sold 6,800 shares (Common Stock) at a price of $30.99 per share, resulting in proceeds of $210,732. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.6K
0% 3M change
0% 12M change
Total Value Held $13,560

Richard A. Edlin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 06 2022
SELL
Open market or private sale
$210,732 $30.99 p/Share
6,800 Reduced 23.13%
22,600 Common Stock
RAE

Richard A. Edlin

Director
Woodcliff Lake, NJ

Track Institutional and Insider Activities on EGRX

Follow EAGLE PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EGRX shares.

Notify only if

Insider Trading

Get notified when an Eagle Pharmaceuticals, Inc. insider buys or sells EGRX shares.

Notify only if

News

Receive news related to EAGLE PHARMACEUTICALS, INC.

Track Activities on EGRX